Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Coloplast

447.60 DKK-1.56 %7.9. klo 10.22
Less than 1K followers

COLO B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-1.56 %
+5.05 %
+16.65 %
-3.01 %
-18.08 %
-28.79 %
-42.75 %
-59.93 %
+854.37 %

Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Read more
Market cap
102.14B DKK
Turnover
7.54M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
3.11.
2026

Annual report '26

1.12.
2026

General meeting '26

All
Research
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release04.09.2026 klo 12.22

Supporting the continued long-term and stable ownership of Coloplast

Coloplast
Analyst Comment18.08.2026 klo 08.46

HCA Red Flag: Coloplast exceeds sales expectations but misses profit target (AI)

Coloplast exceeded expectations where it mattered: organic growth of 6% vs. the guided 5.6%, and sales of MDKK 7,355. DKK vs. MDKK 7,267. DKK. However, the operating profit disappointed at DKK 1,929 million. DKK, and the fish skin business Kerecis contracted again, so the share should open stable rather than strong.

Coloplast
Regulatory press release18.08.2026 klo 08.30

Coloplast A/S - Interim Financial Report, 9M 2025/26

Coloplast

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release17.08.2026 klo 18.06

Coloplast A/S - Announcement no. 6/2026 - Coloplast announces changes to Executive Leadership Team

Coloplast
Press release03.06.2026 klo 16.00

Coloplast’s Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of men

Coloplast
Regulatory press release12.05.2026 klo 08.30

Coloplast A/S - Announcement no. 05/2026 - Interim Financial Report, H1 2025/26

Coloplast
Press release01.05.2026 klo 16.00

Coloplast Receives Innovative Technology Contract from Vizient for Biatain® Silicone Fit

Coloplast
Regulatory press release23.04.2026 klo 20.50

Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis

Coloplast
Press release22.04.2026 klo 20.08

Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST

Coloplast
Regulatory press release12.03.2026 klo 18.01

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release11.03.2026 klo 20.25

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release10.03.2026 klo 16.39

Coloplast A/S - Allocation of Share Options

Coloplast
Regulatory press release09.03.2026 klo 21.50

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release08.03.2026 klo 23.48

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release05.03.2026 klo 19.04

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release04.03.2026 klo 20.52

Coloplast appoints Gavin Wood as new CEO

Coloplast
Regulatory press release11.02.2026 klo 16.36

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast
Regulatory press release06.02.2026 klo 08.30

Coloplast A/S - Interim Financial Report, Q1 2025/26

Coloplast
Press release26.01.2026 klo 14.02

Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET

Coloplast
Regulatory press release18.12.2025 klo 16.00

Coloplast announces changes to Executive Leadership Team

Coloplast